ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Why eCOA Data Reporting Often Falls Short (And What To Do About It)

  By nature, eCOA and ePRO solutions are designed so it’s easy for clinicians and patients to provide clinical trial information. But this is only part of the equation. Discover how eCOA and ePRO solutions also need a thoughtful back-end experience. 

• The Future Of Data Linkage In Clinical Trial Evidence Generation

  Explore key questions about the future of AI and data linkage in clinical trial evidence generation.

• Overcoming Participant Compliance Challenges In A Medical Device Study

  Uncover how Catalyst Clinical Research enhanced participant compliance and streamlined scheduling for a TENS device study using the TrialKit platform, with crucial support from CDS.

• Who Decides? Navigating AI Governance in Clinical Research

  AI in clinical research poses governance challenges. Clear ownership, consistent policies, and aligned teams help manage risk, ensure compliance, and drive responsible innovation in complex trials.

• A Guide To Medical Coding In Clinical Trials

  Medical coding transforms free-text clinical data into standardized terminology, enabling consistent analysis, safety monitoring, and regulatory review. Clear guidelines and quality control help reduce variability and protect data integrity across the entire clinical trial lifecycle.

• Email: The Gold Standard For Clinical Trials

  Although non-verbal conversations between friends are now primarily conducted through text messages or similar apps, see why email remains the standard mode for businesses and organizations.

• Global Pharma Enables Remote Sample Collection With eCOA Solution

  Unearth how a worldwide pharmaceutical company was able to facilitate the remote collection of stool specimens from patients at their residences as needed for research on infectious diseases.

• CRO Uses CRIO eSource To Double Monitoring Productivity

  Examine the transformative impact of eSource technology on monitoring productivity during a global Phase 3 trial conducted by a Contract Research Organization (CRO) amid the COVID-19 pandemic.

• How eSource Reduced Benchmark's Protocol Deviations By Almost 40%

  Explore how a leading vaccine site network selected CRIO to help address the challenges with it's use of paper charts in collecting source data.

• Setting A New Client Standard In Study Closeout Timelines

  Learn how a top-10 global pharmaceutical company achieved a significantly faster time to market for a high-profile therapy.